Abstract
The present study aimed at evaluating the role of IL-1β −511 promoter and IL-1β +3953 exon 5 gene polymorphisms in the risk of developing rheumatoid arthritis (RA) and its correlation to disease activity in Egyptian patients. Thirty-two patients having RA as defined by American College of Rheumatology and 20 healthy control subjects were included. All were subjected to DNA analysis for IL-1β −511and IL-1β +3953 gene polymorphisms using PCR-RFLP technique with restriction enzymes AvaI and TaqI, respectively. No special pattern of association could be detected either between IL-1β −511 and +3953 gene polymorphisms and disease susceptibility or between the polymorphisms and the disease activity parameters represented by disease activity score 28 (DAS 28), ESR, and number of swollen and tender joints. Allele distribution failed as well to detect any association with either disease susceptibility or activity; however, a trend towards positive association involving IL-1β −511 C allele was observed (P = 0.054). Our results suggest that IL-1β −511 and IL-1β +3953 gene polymorphisms do not influence the susceptibility to acquire RA in our population with no relation to disease activity. The complex role of the genetic factors in RA and the magnitude of the effects will require further thorough confirmations in other populations and on larger samples to acknowledge this issue.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H (2006) Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin Exp Rheumatol 24:643–8
Arned WP, Dayer JM (1995) Inhibition of the production and effects of interleukin -1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheumatol 38:151–60
Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol 31:315–24
Brennan FM, McInnes B (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 11:3537–45
Camargo JF, Correa PA, Castiblanco J, Anaya JM (2004) Interleukin-1 beta polymorphism in Colombian patients with autoimmune rheumatic disease. Genes Immun 5:609–14
Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engel J Med 344:907–16
Cutolo M (2004) IL-1Ra: its role in rheumatoid arthritis. Reumatismo 56:41–5
Genevay S, Di Giovine FS, Perneger TV, Silvestri S, Stingelin S, Duff G (2002) Association of IL-4 and IL-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum 47:303–19
Havemose-Poulsen A, Sørensen LK, Bendtzen K, Holmstrup P (2007) Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 78:475–92
John S, Worthington J (2001) Genetic epidemiology: approaches to the genetic analysis of rheumatoid arthritis. Arthritis Res 3:216–20
Johnsen AK, Plenge RM, Butty V, Campbell C, Dieguez-Gonzalez R, Gomez-Reino JJ, Shadick N, Weinblatt M, Gonzalez A, Gregersen PK, Benoist C, Mathis D (2008) A broad analysis of IL-1 polymorphism and rheumatoid arthritis. Arthritis Rheum 58:1947–57
Kazkaz L, Marotte H, Hamwi M, Cazalis MA, Roy P, Miossec P (2007) Rheumatoid arthritis and genetic markers in Syrian and French populations: different impact of the shared epitope. Ann Rheum Dis 66:195–201
Larsen A (1995) How to apply Larsen score in evaluating radiographs of RA in long term studies. J Rheumatol 10:1974–5
Lee YH, Dae JI, Song GG (2009) Association between IL-1 polymorphism and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol 36:12–5
Pawlik A, Kurzawski M, Florczak M, Gawronska Szklarz B, Herczyńska M (2005) IL1beta +3953 exon 5 and IL-2−330 promoter polymorphisms in patients with rheumatoid arthritis. Clin Exp Rheumatol 23:159–64
Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–8
Tolusso B, Pietrapertosa D, Morelli A, Gremese E, Farina G, Carniello F et al (2006) IL-1B and IL-RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7:683–95
Trowsdale J (1993) Genomic structure and function in MHC. Trends Genet 9:117–21
van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–50
You CG, Li JF, Xie XD, Zhu Y, Li PQ, Chen YR (2007) Association of IL-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population. Clin Chem Lab Med 45:968–71
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Darwish, R.K., Ramadan, D.I., Mohy, A.M. et al. Interleukin-1 β gene polymorphisms in Egyptian patients with rheumatoid arthritis. Comp Clin Pathol 23, 689–694 (2014). https://doi.org/10.1007/s00580-012-1672-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-012-1672-6